UBIO

Proshares UltraPro NASDAQ Biotechnology

Delisted

UBIO was delisted on the 27th of March, 2020.

7 hedge funds and large institutions have $1.43M invested in Proshares UltraPro NASDAQ Biotechnology in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
Holders Change %
0%
% of All Funds
0.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
2
Closed
1
Calls
$236K
Puts
$4K
Net Calls
+$232K
Net Calls Change
-$62K
Name Holding Trade Value Shares
Change
Shares
Change %
Jane Street
1
Jane Street
New York
$850K +$381K +13,001 +81%
VF
2
Virtu Financial
New York
$244K -$108K -3,683 -31%
EWA
3
Exencial Wealth Advisors
Oklahoma
$209K +$209K +7,125 New
TRCT
4
Tower Research Capital (TRC)
New York
$72K -$352K -12,019 -83%
Morgan Stanley
5
Morgan Stanley
New York
$24K
LTFS
6
Ladenburg Thalmann Financial Services
Florida
$21K
Simplex Trading
7
Simplex Trading
Illinois
$9K +$5.14K +180 +133%
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
-$801K -40,030 Closed